Immunefi vs Chainlink — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Chainlink trades at Rp153,884 (market cap Rp114,84T, Rp5,22T 24h volume). The key difference: Chainlink is far larger — about 4248612.7× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 748,1M / 1B LINK (75%) for Chainlink. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Chainlink for 62 Days on average.
| IMU | LINK | |
|---|---|---|
Market Cap | Rp27,03M | Rp114,84T |
Volume (24h) | Rp39,91M | Rp5,22T |
Circulating Supply | 873,4M / 10B IMU (9%) | 748,1M / 1B LINK (75%) |
Typical Hold Time | 5 Days | 62 Days |
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
Chainlink (LINK) is trading at Rp154,089 with a market cap of Rp115.01T, showing bullish technical momentum with moving averages supporting upward trends while oscillators remain neutral. The token is approaching key resistance at Rp154,677 after recent positive developments including former Chainlink executive Taylor Lindman joining the SEC's Crypto Task Force as Chief Counsel. With 75% of the 1M LINK maximum supply in circulation and average hold time of 62 days, the network maintains steady token distribution.
Overall outlook remains cautiously optimistic with technical strength but overbought RSI signals suggesting potential near-term consolidation. Key opportunities include Chainlink's growing role in blockchain interoperability, while risks involve regulatory uncertainty and typical crypto volatility. Investors should monitor the Rp157,885 resistance level for breakout confirmation.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →